P21 MRNA TARGET AREAS FOR SILENCING

Compositions of matter comprising RNA silencing molecules capable of mediating cleavage of p21 mRNA are disclosed. Methods of eradicating senescent cells or cancer cells, as well as methods of treating senescence-associated diseases or disorders, cancer, and fibrotic diseases and disorders are also...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: RAICHLIN, Dina, KATZ-KADOSH, Etti, BARKEY, Shirin, PILPEL, Noam, KNANY, Alaa, BOROVSKY, Noam, SHAPIRO, Anastasia, OVADYA, Yossi, GILLIS, Ella, COHEN, Noam, KRIEGER, Gat, BACHELET, Ido
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator RAICHLIN, Dina
KATZ-KADOSH, Etti
BARKEY, Shirin
PILPEL, Noam
KNANY, Alaa
BOROVSKY, Noam
SHAPIRO, Anastasia
OVADYA, Yossi
GILLIS, Ella
COHEN, Noam
KRIEGER, Gat
BACHELET, Ido
description Compositions of matter comprising RNA silencing molecules capable of mediating cleavage of p21 mRNA are disclosed. Methods of eradicating senescent cells or cancer cells, as well as methods of treating senescence-associated diseases or disorders, cancer, and fibrotic diseases and disorders are also disclosed. L'invention concerne des compositions de matière qui comprennent des molécules de silençage d'ARN pouvant assurer la médication du capables de médier le clivage de l'ARNm p21. L'invention concerne également des méthodes pour éradiquer des cellules sénescentes ou des cellules cancéreuses, ainsi que des méthodes pour traiter des maladies ou des troubles associés à la sénescence, le cancer, et des maladies et des troubles fibrotiques.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2022144882A3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2022144882A3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2022144882A33</originalsourceid><addsrcrecordid>eNrjZFAOMDJU8A3yc1QIcQxydw1RcAxydQxWcPMPUgj29HH1c_b0c-dhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHh_kYGRkaGJiYWFkaOxsbEqQIAr-wjNw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>P21 MRNA TARGET AREAS FOR SILENCING</title><source>esp@cenet</source><creator>RAICHLIN, Dina ; KATZ-KADOSH, Etti ; BARKEY, Shirin ; PILPEL, Noam ; KNANY, Alaa ; BOROVSKY, Noam ; SHAPIRO, Anastasia ; OVADYA, Yossi ; GILLIS, Ella ; COHEN, Noam ; KRIEGER, Gat ; BACHELET, Ido</creator><creatorcontrib>RAICHLIN, Dina ; KATZ-KADOSH, Etti ; BARKEY, Shirin ; PILPEL, Noam ; KNANY, Alaa ; BOROVSKY, Noam ; SHAPIRO, Anastasia ; OVADYA, Yossi ; GILLIS, Ella ; COHEN, Noam ; KRIEGER, Gat ; BACHELET, Ido</creatorcontrib><description>Compositions of matter comprising RNA silencing molecules capable of mediating cleavage of p21 mRNA are disclosed. Methods of eradicating senescent cells or cancer cells, as well as methods of treating senescence-associated diseases or disorders, cancer, and fibrotic diseases and disorders are also disclosed. L'invention concerne des compositions de matière qui comprennent des molécules de silençage d'ARN pouvant assurer la médication du capables de médier le clivage de l'ARNm p21. L'invention concerne également des méthodes pour éradiquer des cellules sénescentes ou des cellules cancéreuses, ainsi que des méthodes pour traiter des maladies ou des troubles associés à la sénescence, le cancer, et des maladies et des troubles fibrotiques.</description><language>eng ; fre</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220922&amp;DB=EPODOC&amp;CC=WO&amp;NR=2022144882A3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220922&amp;DB=EPODOC&amp;CC=WO&amp;NR=2022144882A3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>RAICHLIN, Dina</creatorcontrib><creatorcontrib>KATZ-KADOSH, Etti</creatorcontrib><creatorcontrib>BARKEY, Shirin</creatorcontrib><creatorcontrib>PILPEL, Noam</creatorcontrib><creatorcontrib>KNANY, Alaa</creatorcontrib><creatorcontrib>BOROVSKY, Noam</creatorcontrib><creatorcontrib>SHAPIRO, Anastasia</creatorcontrib><creatorcontrib>OVADYA, Yossi</creatorcontrib><creatorcontrib>GILLIS, Ella</creatorcontrib><creatorcontrib>COHEN, Noam</creatorcontrib><creatorcontrib>KRIEGER, Gat</creatorcontrib><creatorcontrib>BACHELET, Ido</creatorcontrib><title>P21 MRNA TARGET AREAS FOR SILENCING</title><description>Compositions of matter comprising RNA silencing molecules capable of mediating cleavage of p21 mRNA are disclosed. Methods of eradicating senescent cells or cancer cells, as well as methods of treating senescence-associated diseases or disorders, cancer, and fibrotic diseases and disorders are also disclosed. L'invention concerne des compositions de matière qui comprennent des molécules de silençage d'ARN pouvant assurer la médication du capables de médier le clivage de l'ARNm p21. L'invention concerne également des méthodes pour éradiquer des cellules sénescentes ou des cellules cancéreuses, ainsi que des méthodes pour traiter des maladies ou des troubles associés à la sénescence, le cancer, et des maladies et des troubles fibrotiques.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFAOMDJU8A3yc1QIcQxydw1RcAxydQxWcPMPUgj29HH1c_b0c-dhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHh_kYGRkaGJiYWFkaOxsbEqQIAr-wjNw</recordid><startdate>20220922</startdate><enddate>20220922</enddate><creator>RAICHLIN, Dina</creator><creator>KATZ-KADOSH, Etti</creator><creator>BARKEY, Shirin</creator><creator>PILPEL, Noam</creator><creator>KNANY, Alaa</creator><creator>BOROVSKY, Noam</creator><creator>SHAPIRO, Anastasia</creator><creator>OVADYA, Yossi</creator><creator>GILLIS, Ella</creator><creator>COHEN, Noam</creator><creator>KRIEGER, Gat</creator><creator>BACHELET, Ido</creator><scope>EVB</scope></search><sort><creationdate>20220922</creationdate><title>P21 MRNA TARGET AREAS FOR SILENCING</title><author>RAICHLIN, Dina ; KATZ-KADOSH, Etti ; BARKEY, Shirin ; PILPEL, Noam ; KNANY, Alaa ; BOROVSKY, Noam ; SHAPIRO, Anastasia ; OVADYA, Yossi ; GILLIS, Ella ; COHEN, Noam ; KRIEGER, Gat ; BACHELET, Ido</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2022144882A33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2022</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>RAICHLIN, Dina</creatorcontrib><creatorcontrib>KATZ-KADOSH, Etti</creatorcontrib><creatorcontrib>BARKEY, Shirin</creatorcontrib><creatorcontrib>PILPEL, Noam</creatorcontrib><creatorcontrib>KNANY, Alaa</creatorcontrib><creatorcontrib>BOROVSKY, Noam</creatorcontrib><creatorcontrib>SHAPIRO, Anastasia</creatorcontrib><creatorcontrib>OVADYA, Yossi</creatorcontrib><creatorcontrib>GILLIS, Ella</creatorcontrib><creatorcontrib>COHEN, Noam</creatorcontrib><creatorcontrib>KRIEGER, Gat</creatorcontrib><creatorcontrib>BACHELET, Ido</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>RAICHLIN, Dina</au><au>KATZ-KADOSH, Etti</au><au>BARKEY, Shirin</au><au>PILPEL, Noam</au><au>KNANY, Alaa</au><au>BOROVSKY, Noam</au><au>SHAPIRO, Anastasia</au><au>OVADYA, Yossi</au><au>GILLIS, Ella</au><au>COHEN, Noam</au><au>KRIEGER, Gat</au><au>BACHELET, Ido</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>P21 MRNA TARGET AREAS FOR SILENCING</title><date>2022-09-22</date><risdate>2022</risdate><abstract>Compositions of matter comprising RNA silencing molecules capable of mediating cleavage of p21 mRNA are disclosed. Methods of eradicating senescent cells or cancer cells, as well as methods of treating senescence-associated diseases or disorders, cancer, and fibrotic diseases and disorders are also disclosed. L'invention concerne des compositions de matière qui comprennent des molécules de silençage d'ARN pouvant assurer la médication du capables de médier le clivage de l'ARNm p21. L'invention concerne également des méthodes pour éradiquer des cellules sénescentes ou des cellules cancéreuses, ainsi que des méthodes pour traiter des maladies ou des troubles associés à la sénescence, le cancer, et des maladies et des troubles fibrotiques.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_WO2022144882A3
source esp@cenet
subjects BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
title P21 MRNA TARGET AREAS FOR SILENCING
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T14%3A04%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=RAICHLIN,%20Dina&rft.date=2022-09-22&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2022144882A3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true